Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliografía
[1.]
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)..
Lancet, (1998), 352 pp. 854-865
[2.]
A. Goday, J. Franch, M. Mata.
Criterios y pautas de terapia combinada en la diabetes tipo 2. Documento de consenso..
Endocrinología y Nutrición, (2001), 48 pp. 82-97
[3.]
J.L. Johnson, S.L. Wlf, U.M. Kabadi.
Efficacy of Insulin and sulphonylurea combination therapy in type 2 diabetes. A Meta-analysis of the Randomized Placebo-Controlled Trials..
Arch Intern Med, (1996), 156 pp. 259-264
[4.]
H. Yki-Jarvinen, M. Kauppila, E. Kjansuu, J. Lahti, T. Marjanen.
Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus..
N Engl J Med, (1992), 327 pp. 1426-1433
[5.]
A.C. Robinson, J. Burke, S. Robinson, D.G. Johnston, R.S. Elkeles.
The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control..
Diabetes Care, (1998), 21 pp. 701-705
[6.]
H. Yki-Jarvinen, L. Ryysy, K. Nikkila, T. Tolukas, R. Vanamo, M. Heikkila.
Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial..
Ann Intern Med, (1999), 130 pp. 389-396
[7.]
L. Aviles-Santa, J. Sinding, P. Raskin.
Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial..
Ann Intern Med, (1999), 131 pp. 182-188
[8.]
F. Relimpio, A. Pumar, F. Losada, M.A. Mangas, D. Acosta, R. Astorga.
Adding metformin versus insulin dose increase in insulin-treated bud poorly controlled type 2 diabetes mellitus. An open-label randomized trial..
Diabetic Med, (1998), 15 pp. 997-1002
[9.]
D.E. Kelly, P. Bidot, Z. Freedman, B. Haag, D. Podlecki, et al.
Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes..
Diabetes Care, (1998), 21 pp. 2056-2061
[10.]
S, P. Raskin, V. Fonseca, J.F. Graveline.
Effect of troglitazone in insulintreated patients with type 2 diabetes. Troglitazone and Exogenous Insulin Study Group..
N Engl J Med, (1998), 338 pp. 861-866
Copyright ©
2002. Elsevier España, S.L.. Todos los derechos reservados
